The 24 references in paper E. Surkova A., N. Kuzubova A., T. Ses’ P., N. Egorova V., Areg Totolian A., Е. Суркова А., Н. Кузубова А., Т. Сесь П., Н. Егорова В., Арег Тотолян А. (2014) “УРОВЕНЬ TGFΒ В СЫВОРОТКЕ КРОВИ И БРОНХОАЛЬВЕОЛЯРНОМ ЛАВАЖЕ БОЛЬНЫХ ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНЬЮ ЛЕГКИХ // TRANSFORMING GROWTH FACTOR Β IN BLOOD SERUM AND BRONCHOALVEOLAR LAVAGE FLUID IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE” / spz:neicon:mimmun:y:2008:i:1:p:93-98

1
Авдеев С.Н. Обострение ХОБЛ: значение инфекционного фактора и антибактериальная терапия // РМЖ. – 2003. – No 22. – С. 1205­1211.
(check this in PDF content)
2
Суркова Е.А., Кузубова Н.А., Сесь Т.П., Соло­ губ Т.С., Резцова Ю.В., Яковлева Н.В., Егорова Н.В. Дисбаланс цитокинов IL­1β и IL­1ra в сыворотке крови и жидкости бронхоальвеолярного лаважа у больных ХОБЛ // Медицинская иммуноло­ гия. – 2006. – No 5­6. – С. 667­672.
(check this in PDF content)
3
Шмелев Е.И. Хроническая обструктивная болезнь легких. – Москва, 2003. – 112 с.
(check this in PDF content)
4
Шмелев Е.И, Бумагина Р.К., Мизарева Ю.Т. Феномен антигенспецифической супрессивной функциональной активности нейтрофилов пери­ ферической крови у больных хроническим брон­ хитом и абсцессом легкого // Иммунология. – 1981. – No 3. – С. 61­64.
(check this in PDF content)
5
Adams D., Hathaway M., Shaw J., Burnett D. Transforming Growth factor β induces human T­lymphocyte migration in vitro // J. Immunol. – 1991. – Vol. 147. – P. 609­612.
(check this in PDF content)
6
Barnes P. Mediators of Chronic Obstructive Pul­ monary Disease // Pharmacol. Rev. – 2004. – Vol. 56. – P. 515­548.
(check this in PDF content)
7
Boer W., Schadewijk A., Sont J., Sharma H. Transforming Growth factor β and recruitment of macrophage and mast cells in airways in Chronic Obstructive Pulmonary Disease // Am. J. Respir. Crit. Care Med. – 1998. – Vol. 158. – P. 1951­1957.
(check this in PDF content)
8
Camoretti­Mercado B., Solway J. Transforming Growth factor β1 and disorders of the lung // Cell Biochem. Biophys. – 2005. – Vol. 43. – P. 131­148.
(check this in PDF content)
9
Domogata­Kulawic J., Hoser G., Safianovska A., Gruberg­Jaworska H., Chasan R. Elevated TGF beta 1 concentration in bronchoalveolar lavage fluid from patients with primary lung cancer // Arch. Immunol. Ther. Exp. – 2006. – Vol. 54. – P. 143­147.
(check this in PDF content)
10
Fadok V., Bratton D., Konowal A., Freed P., Westcott J., Henson P. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracine mechanisms involving TGF­beta, PGE2 and PAF // J. Clin. Invest. – 1998. – Vol. 101. – P. 890­898.
(check this in PDF content)
11
Finlay G., O’Donnell M.D., O’Conner C.M., Hayes J., FitzGerald M. Elastin and collagen remodeling in emphysema: a scanning electron microscopy study // Am. J. Pathol. – 1996. – Vol. 149. – P. 1405­1415.
(check this in PDF content)
12
Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnostic, Management and prevention of COPD. NHLBI/ WHO workshop report. Bethesda, National heart, Lung and Blood Institute. update.2006. http//www. goldcopd.com.
(check this in PDF content)
13
Hodge S., Hodge G., Reynolds P., Scicchitano R., Holmes M. Increased production of TGFβ and apoptosis of T lymphocytes isolated from peripheral blood in COPD // Am. J. Physiol. Lung. – 2003. – Vol. 285. – P. 492­499.
(check this in PDF content)
14
Lang M., Fiaux G., Gillooly M. Collagen content of alveolar wall tissue in emphysematous and non­ emphysematous lungs // Thorax. – 1994. – Vol. 49. – P. 319­326.
(check this in PDF content)
15
Lee H., Rich S., Differential activation of CD8+ T­cells by Transforming Growth factor β // J. Immunol. – 1993. – Vol. 151. – P. 668­677.
(check this in PDF content)
16
McKarns S., Letterio J., Kaminski N. Concentration­depended bifunctional effect of TGF­ beta 1 on immunoglobulin production: a role Smad3 in IgA production in vitro // Int. Immunofarmacol. – 2003. – Vol. 3. – P. 1761­1774.
(check this in PDF content)
17
Mac Nee W. Pathogenesis of Chronic Obstruc­ tive Pulmonary Disease // Proc. Am. Thorac. Soc. – 2005. – Vol. 2. – P. 258­266.
(check this in PDF content)
18
Majo J., Ghezzo H., Cosio M. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema // Eur. Resp. J. – 2001. – Vol. 17. – P. 945­953.
(check this in PDF content)
19
Pepper M., Vassalli J., Orci L., Montesano R. Biphasic effect of Transforming Growth factor β1 on in vitro angiogenesis // Exp. Cell Res. – 1993. – Vol. 204. – P. 356­363.
(check this in PDF content)
20
Pons A., Sauleda J., Noguera A., Pons J. Decreased macrophage release of TGF­β and TIMP­1 in Chronic Obstructive Pulmonary Disease // Eur. Resp. J. – 2005. – Vol. 26. – P. 60­66.
(check this in PDF content)
21
Shapiro S., Ingenito E. The pathogenesis of Chronic Obstructive Pulmonary Disease: advances in the past 100 years // Am. J. Resp. Cell Moll. Biol. – 2005. – Vol. 32. – P. 367­372.
(check this in PDF content)
22
Takizawa H., Tanaka M., Takami K., Ohtoshi T., Ito K., Saton M. Increased expression of Transforming Growth factor β1 in small airway epithelium from tobacco smokers and patients with Chronic Obstructive Pulmonary Disease // Am. J. Respir. Crit. Care Med. – 2001. – Vol. 163. – P. 1476­1483.
(check this in PDF content)
23
Voelkin N., Tuder R. Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension // Eur. Resp. J. – 1995. – Vol. 8. – P. 2129­2138.
(check this in PDF content)
24
Wahl S., Hunt D., Wakefield L., McCatney­ Francis N. Transforming Growth factor type β induced monocyte chemotaxis and growth factor production // Proc. Natl. Acad. Sci. USA. – 1987. – Vol. 84. – P. 5788­5792.
(check this in PDF content)